 Prognostic value bronchoalveolar lavage lymphocyte count pulmonary sarcoidosis prognostic value bronchoalveolar lavage BAL lymphocyte count patients months untreated sarcoidosis men women mean age period months months chest roentgenograms pulmonary function tests patients steroid treatment study period proportion treated patients group BAL lymphocyte count equal percent diagnosis group lymphocytes percent total group significant change TLC FRC FVC DLCO follow-up groups initial high lymphocyte count treated group BAL lymphocyte percent improvement FVC steroid treatment mean duration months correlation lung volumes DCO BAL lymphocyte count time diagnosis helpful predictor lung function deterioration sarcoidosis useful response treatment